Información del producto
RO 8994 is a MDM2 inhibitor that has been shown to inhibit the proliferation of myeloproliferative disorders. It has been found to be an effective treatment for primary myelofibrosis, which is characterized by excessive production of blood cells in the bone marrow. The drug blocks the binding of interferons to their receptors, which leads to reduced levels of interferon-induced proteins and decreased expression of PD-L1 on T cells. This drug also inhibits the production and release of cytokines from T cells, which may lead to cancer and other autoimmune diseases. RO 8994 is a non-nucleoside with a novel mechanism of action that binds to the pd-1 receptor and prevents its activation.
Propiedades químicas
Consulta técnica sobre: 3D-JCC68494 RO 8994
Si desea solicitar un presupuesto o realizar un pedido, por favor añada los productos deseados a su carrito y solicite un presupuesto o pedido desde el carrito. Es más rápido, más barato, y podrá beneficiarse de los descuentos y las ventajas disponibles.
